BioSpace News Archive

Biotech Bay

RenovoRx Sponsors Pancreatic Cancer Action Network’s PurpleStride® Event

RenovoRx, Inc., a biopharmaceutical company focused on the localized treatment of solid tumors, announced it joined Pancreatic Cancer Action Network as a sponsor of the organization’s PurpleStride Silicon Valley event, this past Saturday, April 29, 2023.

May 1, 2023
·
4 min read
BioMidwest

Athersys to Participate in The Cellular Therapies and Transfusion Medicine in Trauma and Critical Care Conference

Athersys, Inc. announced today their participation in the Cellular Therapeutics in Trauma and Critical Care’s (CTTACC) conference, “Cellular Therapies and Transfusion Medicine in Trauma and Critical Care,” from May 8-11, 2023 in Scottsdale, Arizona.

May 1, 2023
·
4 min read
Biotech Bay

Napo Therapeutics Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress in Abu Dhabi

Jaguar Health, Inc. today announced that Napo Therapeutics is a Platinum Sponsor of the 9th Annual Elite Ped-GI Congress, which takes place May 4-6, 2023 in Abu Dhabi in the United Arab Emirates.

May 1, 2023
·
4 min read
Business

Biora Therapeutics Appoints Dr. Ariella Kelman as Chief Medical Officer

Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced the appointment of Ariella Kelman, MD, as Chief Medical Officer.

May 1, 2023
·
6 min read
Business

Cassava Sciences Reports Q1 2023 Financial Results and Operating Updates

Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced financial results for the first quarter ended March 31, 2023.

May 1, 2023
·
9 min read
Biotech Beach

New Research Demonstrates Potential of Jumpcode Genomics Depletion Technology to Improve Pandemic Response

Jumpcode Genomics today announced the results of a new study demonstrating the potential of Jumpcode Genomics depletion technology for improving future large-scale infectious disease testing and pandemic response.

May 1, 2023
·
4 min read
Business

Therapeutic Solutions International Launches VasoSome Vascular Inc Based on Successful Treatment of Aortic Aneurysms using Patent Pending Exosome Therapy

Therapeutic Solutions International (TSOI) announced formation of a new spin-off company, VasoSome Vascular Inc, focused on treating the “living timebomb” condition of aortic aneurysms using stem cell derived exosomes.

May 1, 2023
·
2 min read
BioMidwest

Clinical Study Shows 92% of Patients Report Resolution of Migraine Headaches Using Vivos’ POD® Appliance Treatment

Vivos Therapeutics, Inc. announced the results of a recent clinical observational study on the application of Vivos’ recently acquired Preventive Oral Device® in the treatment and prevention of migraine headaches.

May 1, 2023
·
5 min read
Business

Marker Therapeutics Announces Comprehensive Non-Dilutive Agreement With CellReady™

Marker Therapeutics, Inc. today announced that it has entered into a comprehensive agreement with CellReady™, a newly formed Contract Development and Manufacturing Organization (CDMO) founded by John Wilson, founder and CEO of Wilson Wolf Corporation and Marker Co-Founder and Board Member.

May 1, 2023
·
9 min read
Business

AVROBIO Announces Leadership Transition

AVROBIO, Inc. today announced the appointment of Erik Ostrowski as interim Chief Executive Officer effective as of today.

May 1, 2023
·
7 min read